It’s not great when a company needs a rival to have a major disaster in order to see the upside, but when you are Boston Scientific (NYSE: BSX), it may be welcome news indeed. That is the queer situation Boston Scientific finds itself in at the close of a tough year. Or at least that […]
St. Jude Medical (NYSE:STJ) CEO Dan Starks told analysts Wednesday that the company estimates it will pay about $60 million as a result of the medical device tax in 2013, and described it as a tax that will have an unintended negative impact on the medical device industry. In a call discussing results of the […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.